January 10, 2025 07:26 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
8 labourers still trapped in Assam's flooded mine even after 3 days of rescue ops | SC refuses to hear petitions seeking review of its same-sex marriage judgement, says there is 'no error' | 'They should wind up the alliance': Omar Abdullah on AAP-Congress fight over Delhi elections | Pune woman killed by her colleague in full public view for not paying back his money, no one intervenes | Los Angeles wildfire leaves 5 dead, forces 1 lakh including celebs to flee, Hollywood hills ablazed | PM Modi condoles death of six people in Tirupati stampede incident | Days after condemning Pak airstrikes, India in a first engages with Afghanistan's Taliban regime | 6 dead in stampede near Tirupati temple during token distribution to offer prayers | Prominent journalist-film producer Pritish Nandy dies of cardiac arrest at 73 | Thousands, including Hollywood stars, flee Los Angeles upscale neighbourhood as wildfire engulfs homes
Hetero receives emergency use nod by DCGI for Covid drug Tocilizumab

Hetero receives emergency use nod by DCGI for Covid drug Tocilizumab

Sep 06, 2021, at 08:46 pm

Hyderabad/UNI: Hetero, the Hyderabad-based pharma major, announced on Monday that the Drugs Controller General of India (DCGI) has issued approval for restricted use, Emergency Use Authorization (EUA) for the generic version of Tocilizumab in India.